Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Pediatric Blood and Cancer

eISSN: 1545-5017pISSN: 1545-5009

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
4.8
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.29
Time to Publish
time-to-publish View Chart
5  Mo

Journal Specifications

Overview
  • Publisher
    WILEY
  • Language
    English
  • Frequency
    Monthly
General Details
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 15%
4-6 57%
7-9 21%
>9 7%

Topics Covered

Cancer
Overall survival
Sarcoma
Bone marrow
Chemotherapy
Sirolimus
Hepatoblastoma
Anemia
Hematopoietic stem cell transplantation
Retinoblastoma
Central nervous system
Toxicity
Osteosarcoma
Lymphoblastic Leukemia
Proton therapy
Oncology
Methotrexate
Neutropenia
Hemoglobin
Ependymoma

Year-wise Publication

FAQs

Since when has Pediatric Blood and Cancer been publishing? Faqs

The Pediatric Blood and Cancer has been publishing since 2004 till date.

How frequently is the Pediatric Blood and Cancer published? Faqs

Pediatric Blood and Cancer is published Monthly.

Who is the publisher of Pediatric Blood and Cancer? Faqs

The publisher of Pediatric Blood and Cancer is WILEY.

How can I view the journal metrics of Pediatric Blood and Cancer on editage? Faqs

For the Pediatric Blood and Cancer metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Pediatric Blood and Cancer? Faqs

The eISSN number is 1545-5017 and pISSN number is 1545-5009 for Pediatric Blood and Cancer.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Overall survival, Sarcoma, Bone marrow, Chemotherapy, Sirolimus, Hepatoblastoma, Anemia, Hematopoietic stem cell transplantation, Retinoblastoma, Central nervous system, Toxicity, Osteosarcoma, Lymphoblastic Leukemia, Proton therapy, Oncology, Methotrexate, Neutropenia, Hemoglobin, Ependymoma.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.